与传统常规稻相比，杂交水稻具有增产20%以上的潜力。目前，全球已有超过60个国家将杂交水稻投入商业化种植。杂交水稻通常分为两系法和三系法两种类型，其中两系法杂交水稻具有更多优势，其种植面积已逐渐成为杂交水稻的主要构成部分。在作物育种特别是水稻育种中，两系杂交育种主要利用环境敏感型核雄性不育系，其中温敏型（TGMS）和光敏型（PGMS）不育系是我国实际应用的主要材料。然而，使用TGMS系生产杂交水稻 ...

南京林业大学 林草学院、水土保持学院珍贵树种研究团队在《Plant Biotechnology Journal》上在线发表了题为“Two Indel Variations in the Regulated Carotenoid Pigment ...

This Collection supports and amplifies research related to SDG 2, SDG 3 and SDG 9. Plant biotechnology is undergoing a transformative era, driven by rapid advancements in molecular biology, genetic ...

Plant Molecular Farming (PMF) is an innovative field at the intersection of biotechnology, agriculture, and pharmacology, ...

Plant biotechnology has revolutionised our ability to enhance crop performance, conserve endangered species and understand the intricate genetic architectures underlying plant diversity. This field ...

Conventional plant regeneration approaches by cell culture require the external application of plant growth regulators, including hormones. However, optimizing culture conditions can be laborious. Now ...

A recent breakthrough in biotechnology promises to change the landscape of plant genetic engineering. Imagine a persistent invader—Agrobacterium—long used to deliver genes into plants. Despite its ...

Researchers have successfully uncovered the molecular mechanisms by which bacterial cellulose patches stimulate the regeneration of plant wounds. The regeneration process requires the activation of ...

The 11th International Plant Tissue Culture and Biotechnology Conference concluded on Monday at the Department of Botany, ...

Sylvia Mitchell (left) is Head of the Medicinal Plant Biotechnology Research Group in the Biotechnology Centre at the University of the West Indies (UWI; Mona, Jamaica). She founded this research ...

Anandi Botanicals Inc., an Alberta-based startup, is pioneering sustainable, high-tech agriculture by merging advanced plant biotechnology with AI and robotics. The company seeks research and ...

The global pharmaceutical industry is witnessing a steady transformation as plant-based active pharmaceutical ingredients (APIs) move from complementary roles toward becoming core components in modern ...